SPI
17.143,97
PKT
-175,00
PKT
-1,01
%
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 07.11.12 | Sonova equal-weight | Morgan Stanley | |
| 07.11.12 | Barry Callebaut hold | Vontobel Research | |
| 07.11.12 | Arbonia hold | Vontobel Research | |
| 07.11.12 | Novartis reduce | Vontobel Research | |
| 07.11.12 | Adecco SA buy | Vontobel Research | |
| 07.11.12 | Holcim neutral | Sarasin Research | |
| 07.11.12 | Barry Callebaut neutral | Sarasin Research | |
| 07.11.12 | Schindler hold | Vontobel Research | |
| 07.11.12 | Holcim hold | Vontobel Research | |
| 07.11.12 | Adecco SA outperform | Exane-BNP Paribas SA | |
| 07.11.12 | Adecco SA neutral | J.P. Morgan Cazenove | |
| 07.11.12 | UBS buy | Vontobel Research | |
| 07.11.12 | dormakaba hold | Vontobel Research | |
| 07.11.12 | Burckhardt Compression hold | Vontobel Research | |
| 06.11.12 | Avolta (ex Dufry) outperform | Exane-BNP Paribas SA | |
| 06.11.12 | Avolta (ex Dufry) neutral | UBS AG | |
| 06.11.12 | Swisscom outperform | Exane-BNP Paribas SA | |
| 06.11.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 06.11.12 | Implenia buy | Vontobel Research | |
| 06.11.12 | Forbo International buy | Vontobel Research | |
| 06.11.12 | Avolta (ex Dufry) underperform | Cheuvreux SA | |
| 06.11.12 | Holcim hold | Société Générale Group S.A. (SG) | |
| 06.11.12 | Avolta (ex Dufry) buy | Vontobel Research | |
| 06.11.12 | Burckhardt Compression hold | Vontobel Research | |
| 06.11.12 | Partners Group buy | Sarasin Research | |
| 06.11.12 | dormakaba hold | Vontobel Research | |
| 06.11.12 | Adecco SA buy | Sarasin Research | |
| 06.11.12 | Adecco SA buy | Vontobel Research | |
| 05.11.12 | Swiss Re sell | Goldman Sachs Group Inc. | |
| 05.11.12 | Novartis neutral | Citigroup Corp. | |
| 05.11.12 | Roche neutral | Citigroup Corp. | |
| 05.11.12 | Holcim buy | Société Générale Group S.A. (SG) | |
| 05.11.12 | Partners Group hold | Vontobel Research | |
| 05.11.12 | Partners Group neutral | Sarasin Research | |
| 05.11.12 | Avolta (ex Dufry) buy | Vontobel Research | |
| 05.11.12 | Avolta (ex Dufry) neutral | Sarasin Research | |
| 05.11.12 | Calida hold | Vontobel Research | |
| 05.11.12 | UBS buy | Citigroup Corp. | |
| 06.11.12 | Novartis outperform | Exane-BNP Paribas SA | |
| 02.11.12 | Swiss Re buy | Société Générale Group S.A. (SG) |